Internal Medicine, Hematology & Oncology · Columbus, OH
NPI
1174753537
Since 2009
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
460 W 10th Ave
Columbus, OH, 43210
Phone (614) 293-6529
Groups this clinician bills Medicare through
Medicare paid, 2024
$30K
302 services
Medicare patients, 2024
99
Average age 70
Drug cost, 2024
$1.4M
328 prescriptions
Company payments, 2025
$1,170
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David A Liebner was code 99215 (office e&m - established), 216 times for 73 patients. In total David A Liebner billed 302 services in 8 codes, and Medicare paid $30K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 216 | 73 | $104.75 | $23K |
| 99214 Office E&M - Established | Facility | 42 | 33 | $64.53 | $2,710 |
| 99205 Office E&M - New | Facility | 16 | 16 | $137.42 | $2,199 |
By year: 2022 $35K for 365 services; 2023 $32K for 325 services; 2024 $30K for 302 services.
Medicare prescription drug claims, 2024
In 2024, the drug David A Liebner prescribed most often to Medicare patients was Sorafenib (Sorafenib Tosylate), with 18 prescriptions and refills. In total David A Liebner wrote 328 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sorafenib Sorafenib Tosylate | 18 | 18 | Under 11 | $15K |
| Pazopanib Hcl Generic | 17 | 17 | Under 11 | $101K |
| Levothyroxine Sodium Generic | 16 | 20 | Under 11 | $71.59 |
| Ogsiveo Nirogacestat Hydrobromide | 15 | 15 | Under 11 | $371K |
| Dexamethasone Generic | 15 | 20 | Under 11 | $251 |
| Verzenio Abemaciclib | 15 | 15 | Under 11 | $217K |
| Eliquis Apixaban | 13 | 17 | Under 11 | $9,850 |
| Ondansetron Hcl Generic | 13 | 13 | Under 11 | $94.48 |
| Votrient Pazopanib Hcl | 11 | 11 | Under 11 | $109K |
| Alecensa Alectinib Hcl | 11 | 11 | Under 11 | $187K |
| Prochlorperazine Maleate Generic | 11 | 11 | Under 11 | $146 |
Brand drugs: 120 claims; generic drugs: 208 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David A Liebner $1,170 ($1,170 in general payments such as food, travel and fees) from 3 companies. The largest payer was Deciphera Pharmaceuticals Inc. with $1,170.
| Company | Payments | Amount |
|---|---|---|
| Deciphera Pharmaceuticals Inc. | 1 | $1,170 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.